Connect with us

Investment

Atherton Bikes Seeking Around £600000 in Crowd Funding Investment – Pinkbike.com

Published

 on


Atherton Bikes is seeking around £600,000 ($775,000 USD) in further crowdfunding to help launch the next phase of its business.

The British brand will be using Crowdcube to manage the fundraising. Unlike other crowdfunding platforms, Crowdcube doesn’t offer rewards, products and merchandise to backers but instead a stake in the company. Atherton Bikes have not yet confirmed what percentage of equity will be released to investors.

Investors can join in the funding round from £11 and Atherton Bikes is predicting a 6.1% Compound Annual Growth Rate (CAGR) on investments up to 2025. It is basing this forecast on a projected 7,500 sales in the next five years.

Atherton Bikes began life with some Angel Investors, including the Dragon’s Den businessman Piers Linney, however some equity was held back as the brand wanted to leave some of the pie for mountain bikers and members of the public too. Dan Brown, CEO, said: “Our initial Angel investment round was so successful that we had to close it early to save enough shares for the mountain bike community, something we were all unanimous on. Now we’re aiming to raise a minimum of £600,000 through crowd-funding.on the Crowd Cube platform. Working with our first customers has given us the opportunity to perfect our processes and build the operational confidence to take the company to the next level.”

The crowdfunding will apparently allow Atherton Bikes to bring its additive manufacturing into its own facility with the brand having previously manufactured its prototype frames at Renishaw near Bristol, UK. The investment will expand the brand’s capacity, allow it to launch website sales, and “increase the chances for customers to see, touch and feel our bikes and to develop the next models in the range”.

Gee Atherton said “We believe that Atherton Bikes will disrupt the mountain bike industry. Bringing manufacturing back to the UK and establishing our business with a serious focus on sustainability is a huge bonus. We are working with some amazingly clever scientists and engineers from backgrounds in aerospace, Formula1 and NASA and our fundraising is being led by (Ex BBC Dragons’ Den) Piers Linney so your investment will be in very good hands.”

The crowdfunding has not yet begun but anyone interested can pre-register, here. Investments of this nature carry risks to your capital. Please Invest Aware.

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

Guggenheim Partners prepares to dip investment fund’s toes into Bitcoin – Cointelegraph

Published

 on


An SEC filing on Friday indicates that the next Wall Street institution to take a public position in Bitcoin may also be among the largest yet: the $275 billion financial services firm Guggenheim Partners. 

The Guggenheim filing allows the Macro Opportunities fund to purchase GBTC, a publicly-traded Bitcoin investment vehicle from Grayscale, at an indeterminate point in the future. 

“The Guggenheim Macro Opportunities Fund may seek investment exposure to bitcoin indirectly through investing up to 10% of its net asset value in Grayscale Bitcoin Trust (“GBTC”),” the filing reads.

According to independent ratings firm Morningstar, the Guggenheim Macro Opportunities fund currently has $5.3 billion in assets under management and sports a four-star rating “based on risk-adjusted returns out of 270 Nontraditional Bond funds.”

Guggenheim describes the overall fund strategy for the institutional-grade shares (ticker: GIOIX) as a product of the investment team’s “highest-conviction ideas.” If the fund were to take the full 10% stake in GBTC, it would be worth north of $500 million.

The filing also notes a long list of potential investor risks associated with cryptocurrencies, which it refers to as “digital assets designed to act as a medium of exchange.” Risks include lack of cryptocurrency exchange regulation, GBTC’s historical “significant premium” to net asset value, and uncertainty regarding tax laws and regulations, among others.

This preparatory move by Guggenheim appears to be part of a cascading series of investments indicating increased acceptance of Bitcoin among major financial institutions. In August, business intelligence firm Microstrategy purchased nearly 40,000 Bitcoin, leading to a parabolic move in share price. Likewise, financial services firm Square, Inc bought $50 million in Bitcoin in October.

This rolling snowball of institution interest may quickly become an avalanche, as noted by one prominent voice in crypto journalism: 

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

This Is Where Healthcare Leaders Are Investing Their Money – Forbes

Published

 on


2020 has certainly highlighted the value that a strong healthcare system can provide for a community. Moreover, due to the Covid-19 pandemic, healthcare systems and patients worldwide have turned to more creative solutions in order to deal with crises, deliver care when needed, and innovate as necessary.

Throughout this time, funding and investment in the healthcare industry has by no means slowed down. In fact, the need for innovation in a coronavirus pandemic-driven, socially isolated world has provided even more inspiration for investors to put their money into avenues which can provide viable solutions.

Famed consulting firm PricewaterhouseCoopers and CB Insights recently published a report highlighting the latest trends in venture capital funding for healthcare related industries. These key findings indicate where investors are focusing the majority of their time and efforts, and hence likely portray where the healthcare industry is moving.

Location

In terms of “dollars raised,” the report indicates that Silicon Valley, New England, North Central, San Diego, and the New York Metros are the top 5 regions for healthcare. In Q3 of 2020, Silicon Valley raised nearly $2.5 billion, with New England raising $1.9 billion. But this statistic is not entirely surprising, given the sheer amount of capital and technology talent that’s present in the Silicon Valley area. As some of the world’s largest technology companies are so heavily invested in healthcare, this makes sense. Furthermore, Silicon Valley has always been a “startup” hub, with executives easily transferring their talents from one firm to another, seeking to develop the next innovation. New England is no different, given that it is home to some of the largest pharmaceutical and biomedical innovation companies in the world.

Sectors

On a similar note, biotechnology is the leading subsector in healthcare investments. In Q3, investors poured nearly $3.9 billion into this subsector, marking an astounding 38% increase from Q2 2020, which raised $2.8 billion. The push for new innovation in biotechnology has never been more prevalent—ranging from new ways to develop and test treatments, to novel technological tools and interfaces for healthcare. The second heaviest area of investment was medical devices and equipment, with nearly $892 million raised.

Deals

The largest healthcare deals in Q3 2020 were the following:

a.    Bright Health—Value of Deal: $500 Million

b.    Tizona Therapeutics—Value of Deal: $300 Million

c.    Village MD—Value of Deal: $275 Million

d.    Freenome—Value of Deal: $270 Million

e.    Thrive Earlier Detection—Value of Deal: $257 Million

f.     Recursion Pharmaceuticals—Value of Deal: $239 Million

g.    Instil Bio—Value of Deal: $170 Million

h.    Kronos Bio—Value of Deal: $148 Million

The last three of these, Recursion Pharmaceuticals, Instil Bio, and Kronos Bio are all listed as biotechnology companies, yet again driving the point that biotechnology leads the healthcare investments realm.

Overall, this report provides a very pragmatic yet illuminating picture of where investors are placing their money and time. Indeed, 2020 has truly ignited a fire in many to continue to innovate to solve some of healthcare’s toughest challenges. However, given the cyclical nature of healthcare, and the fact that new technology continues to drive forward medical innovation as quickly as it can get developed, these trends are by no means stagnant. Rather, as with any legitimate industry that fosters growth, healthcare will inevitably continue to undergo dynamic transformation in the coming decades.

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

Verv: "Applying for a new investment was tough" – Innovation Origins

Published

 on


When the UK went into lockdown in mid-March, the small Verv team, surprising as it may sound, was well prepared for the turbulent time ahead of them. “In 2019, we had already made significant cost savings after reviewing our business strategy,” says Louanne Steyn, CFO of Verv, “so we had a good overview of all our costs. We knew what we could do to reduce them in the short term.”

For example, Verv canceled the lease of their London office. “We are a small team and now we all work from home. If necessary, we can rent a space to get together.”

Steyn herself works from Devon, southwest of London. “During this pandemic, it is important to cut costs wherever possible and to be intelligent with spending. This will make a difference later on.”

Better focus on product strategy

Verv already had plans to invest in 2020. At the same time, the start-up focused on the latest predictive maintenance technology currently being applied to household appliances such as washing machines, dishwashers and refrigerators. Verv’s technology measures and analyzes the energy consumption of appliances at very high speeds. By applying specialized algorithms to this data, it is able to detect behavioral anomalies that can signal a fault in the machinery. Due to the high resolution of the technology, errors can be detected and prevented in real time, right down to the level of parts of a device.

Integrated microchip

The solution is available in multiple forms, including built-in firmware on an integrated microchip and an online adapter. By remotely performing a thorough analysis, Verv can provide the manufacturer with a detailed diagnosis and recommendations that can be passed on to repair departments and engineers at the companies involved as well as to consumers who own the device.

With sustainability at its core, Verv wants to offer the market more opportunities to repair rather than replace so that devices and appliances last longer and result in less waste. Steyn thinks that the corona crisis may create new opportunities in the market. “People have less money to spend. They want their things to last longer. Maybe now they’ll start thinking more carefully about the use of raw materials.”

Technology for all electrical products

Manufacturers can integrate the microchip into their devices or devices. But owners of existing devices can also benefit from the predictive maintenance solution. The concept is simple: It uses an online adapter with technology to collect the required data and send it to the platform.

The technology can be applied to any electronic device. “Think of chargers for electric cars where it is important to be able to quickly detect anomalies,” says Steyn. This market is expected to grow due to the need for sustainable transportation.

At one point, Verv was looking for new investments to further develop the technology and prepare for a commercial rollout. “This was a lot harder because investors were first looking at their existing portfolios and were reluctant to invest in new start-ups.”

Re-screened by InnoEnergy

In March, one of the owners of Verv, EIT InnoEnergy, investigated the possibility of reinvesting in some of the start-ups it has in its portfolio. “The process of applying for this was very tough,” says Steyn looking back. “We already knew in 2019 that 2020 would be a challenging year. But corona made that even more difficult.”

Verv further increased its focus on business strategy and product development. At the same time, the company went through the selection procedure set up by the EIT InnoEnergy start-up team. “Now that they have made additional investments, we are in a position to much more easily attract other investors.”

Product delivery likely in 2022

Steyn is happy that Verv is experiencing good traction this year and expects the company to survive the corona crisis. “I have worked for other companies within the circular economy before. I think it’s important to contribute to a more sustainable world with Verv.”

Verv’s business objectives and business strategy will not be greatly influenced by corona, Steyn thinks. Its technology remains on track for mass production, which is likely to start in 2022.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending